Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 意见
• 07/13/23
0
0
嵌入
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论